Literature DB >> 24531895

A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins.

Daniel J Antoine1, Helena Erlandsson Harris2, Ulf Andersson3, Kevin J Tracey4, Marco E Bianchi5.   

Abstract

High mobility group box 1 (HMGB1) is a central mediator in inflammation and immunity. Recently, it was shown that different redox states of the three cysteines of HMGB1 endow it with mutually exclusive activities, such as inducing chemotaxis or the transcription of cytokines and chemokines, via the interaction with different receptors. The different HMGB1 redox forms can be identified by mass spectrometry in body fluids of patients and may hold promise as biomarkers. We propose here a systematic nomenclature of the different redox forms of HMGB1 and related proteins, to replace the conflicting names used so far by different laboratories.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531895      PMCID: PMC3966994          DOI: 10.2119/molmed.2014.00022

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  8 in total

1.  Reading signals on the nucleosome with a new nomenclature for modified histones.

Authors:  Bryan M Turner
Journal:  Nat Struct Mol Biol       Date:  2005-02       Impact factor: 15.369

Review 2.  Regulation of protein function and signaling by reversible cysteine S-nitrosylation.

Authors:  Neal Gould; Paschalis-Thomas Doulias; Margarita Tenopoulou; Karthik Raju; Harry Ischiropoulos
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

Review 3.  Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges.

Authors:  James W Dear; Daniel J Antoine
Journal:  Expert Rev Clin Pharmacol       Date:  2014-01-22       Impact factor: 5.045

4.  Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Authors:  Huan Yang; Peter Lundbäck; Lars Ottosson; Helena Erlandsson-Harris; Emilie Venereau; Marco E Bianchi; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Daniel J Antoine
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

Review 5.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

6.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

7.  Endogenous HMGB1 regulates autophagy.

Authors:  Daolin Tang; Rui Kang; Kristen M Livesey; Chun-Wei Cheh; Adam Farkas; Patricia Loughran; George Hoppe; Marco E Bianchi; Kevin J Tracey; Herbert J Zeh; Michael T Lotze
Journal:  J Cell Biol       Date:  2010-09-06       Impact factor: 10.539

8.  Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release.

Authors:  Emilie Venereau; Maura Casalgrandi; Milena Schiraldi; Daniel J Antoine; Angela Cattaneo; Francesco De Marchis; Jaron Liu; Antonella Antonelli; Alessandro Preti; Lorenzo Raeli; Sara Samadi Shams; Huan Yang; Luca Varani; Ulf Andersson; Kevin J Tracey; Angela Bachi; Mariagrazia Uguccioni; Marco E Bianchi
Journal:  J Exp Med       Date:  2012-08-06       Impact factor: 14.307

  8 in total
  49 in total

Review 1.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

Review 2.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

Authors:  Peter Huebener; Jean-Philippe Pradere; Celine Hernandez; Geum-Youn Gwak; Jorge Matias Caviglia; Xueru Mu; John D Loike; Robert F Schwabe
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 4.  Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming.

Authors:  Matthew G Frank; Michael D Weber; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-03-24       Impact factor: 7.217

5.  HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.

Authors:  Jingjing Cai; Hong Yuan; Qingde Wang; Huan Yang; Yousef Al-Abed; Zhong Hua; Jiemei Wang; Dandan Chen; Jinze Wu; Ben Lu; John P Pribis; Weihong Jiang; Kan Yang; David J Hackam; Kevin J Tracey; Timothy R Billiar; Alex F Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 6.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

7.  Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Authors:  Huan Yang; Haichao Wang; Yaakov A Levine; Manoj K Gunasekaran; Yongjun Wang; Meghan Addorisio; Shu Zhu; Wei Li; Jianhua Li; Dominique Pv de Kleijn; Peder S Olofsson; H Shaw Warren; Mingzhu He; Yousef Al-Abed; Jesse Roth; Daniel J Antoine; Sangeeta S Chavan; Ulf Andersson; Kevin J Tracey
Journal:  JCI Insight       Date:  2016-05-19

Review 8.  HMGB proteins and arthritis.

Authors:  Noboru Taniguchi; Yasuhiko Kawakami; Ikuro Maruyama; Martin Lotz
Journal:  Hum Cell       Date:  2017-09-15       Impact factor: 4.174

9.  The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine.

Authors:  Matthew G Frank; Sweta Adhikary; Julia L Sobesky; Michael D Weber; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-08-04       Impact factor: 7.217

Review 10.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.